Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, pharmacy benefits manager Catamaran (NASDAQ:CTRX.DL) has earned a respected four-star ranking.

With that in mind, let's take a closer look at Catamaran and see what CAPS investors are saying about the stock right now.

Catamaran facts

Headquarters (founded)

Lisle, Ill. (1993)

Market Cap

$10.8 billion

Industry

Healthcare services

Trailing-12-Month Revenue

$8.0 billion

Management

Chairman/CEO Mark Thierer (since 2012)
CFO Jeffrey Park (since 2012)

Return on Equity (average, past 3 years)

10.3%

Cash/Debt

$393.0 million / $1.3 billion

Competitors

Caremark Pharmacy Services
Cerner
Express Scripts

Sources: S&P Capital IQ and Motley Fool CAPS.

On CAPS, 95% of the 362 members who have rated Catamaran believe the stock will outperform the S&P 500 going forward.

Just yesterday, one of those Fools, All-Star echofarmer, took a cautiously bullish stance on Catamaran: "Good cash flow and earnings growth history. The main financial con as I see it is the razor thin [profit margins]. Yikes! Not much room for error here, but good cash position to survive any missteps."

Want to see how well (or not so well) the stocks in this series are performing? Follow the TrackPoisedTo CAPS account.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis -- even one of our own -- helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.